Sfoglia per RIVISTA
EXPERT REVIEW OF ANTICANCER THERAPY
Collezione AO Ordine Mauriziano
Items : 4
Pembrolizumab as a single agent for patients with MSI-H advanced endometrial carcinoma. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2022 Oct;22(10):1039-1047. doi: 10.1080/14737140.2022.2126356. Epub 2022
2022
AO Ordine Mauriziano
Turinetto M; Lombardo V; Pisano C; Musacchio L; Pignata S;
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2022 Jan;22(1):115-121. doi: 10.1080/14737140.2022.2002688. Epub 2021 No
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Procopio G; Verzoni E; De Braud FG; Pignata S; Ottini A; Guadalupi V; Claps M; Sepe P; Stellato M; Buttigliero C; Roviello G; Di Lorenzo G; Mucciarini C; Messina C; Sorarù M; Santini D; Casadei C; Buti S; De Giorgi U; Mennitto A; Zattarin E; Di Maio M; Bimbatti D;
Systemic treatment of hepatocellular carcinoma: why so many failures in the development of new drugs? in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2016 Oct;16(10):1053-62. doi: 10.1080/14737140.2016.1227706. Epub 2016 S
2016
AO Ordine Mauriziano
Brizzi MP; Pignataro D; Tampellini M; Scagliotti GV; Di Maio M;
The role of surgery in recurrent endometrial cancer. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2016 Jul;16(7):741-50. doi: 10.1080/14737140.2016.1190650. Epub 2016 Jun
2016
AO Ordine Mauriziano
Zanfagnin V; Ferrero A; Biglia N; Aletti G; Gill SE; Makdisi PB; Multinu F; Mariani A;